182 related articles for article (PubMed ID: 20853109)
1. Signal characteristics of focal bone marrow lesions in patients with multiple myeloma using whole body T1w-TSE, T2w-STIR and diffusion-weighted imaging with background suppression.
Sommer G; Klarhöfer M; Lenz C; Scheffler K; Bongartz G; Winter L
Eur Radiol; 2011 Apr; 21(4):857-62. PubMed ID: 20853109
[TBL] [Abstract][Full Text] [Related]
2. Apparent diffusion coefficient maps integrated in whole-body MRI examination for the evaluation of tumor response to chemotherapy in patients with multiple myeloma.
Bonaffini PA; Ippolito D; Casiraghi A; Besostri V; Franzesi CT; Sironi S
Acad Radiol; 2015 Sep; 22(9):1163-71. PubMed ID: 26182979
[TBL] [Abstract][Full Text] [Related]
3. Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma.
Narquin S; Ingrand P; Azais I; Delwail V; Vialle R; Boucebci S; Tasu JP
Diagn Interv Imaging; 2013 Jun; 94(6):629-36. PubMed ID: 23683788
[TBL] [Abstract][Full Text] [Related]
4. Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWI.
Eiber M; Holzapfel K; Ganter C; Epple K; Metz S; Geinitz H; Kübler H; Gaa J; Rummeny EJ; Beer AJ
J Magn Reson Imaging; 2011 May; 33(5):1160-70. PubMed ID: 21509875
[TBL] [Abstract][Full Text] [Related]
5. Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences.
Larbi A; Omoumi P; Pasoglou V; Michoux N; Triqueneaux P; Tombal B; Cyteval C; Lecouvet FE
Eur Radiol; 2019 Aug; 29(8):4503-4513. PubMed ID: 30413957
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of Diffuse Infiltration Pattern in Multiple Myeloma From Hyperplastic Hematopoietic Bone Marrow: Qualitative and Quantitative Analysis Using Whole-Body MRI.
Sun M; Cheng J; Ren C; Zhang Y; Li Y; Wang L; Liu Y
J Magn Reson Imaging; 2022 Apr; 55(4):1213-1225. PubMed ID: 34558141
[TBL] [Abstract][Full Text] [Related]
7. Application value of diffusion weighted whole body imaging with background body signal suppression in monitoring the response to treatment of bone marrow involvement in lymphoma.
Sun M; Cheng J; Zhang Y; Wang F; Meng Y; Fu X
J Magn Reson Imaging; 2016 Dec; 44(6):1522-1529. PubMed ID: 27160047
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Diffuse Bone Marrow Infiltration Pattern in Monoclonal Plasma Cell Diseases by Quantitative Whole-body Magnetic Resonance Imaging.
Sun M; Cheng J; Ren C; Zhang Y; Li Y; Wang L; Zhang S; Lin L
Acad Radiol; 2022 Apr; 29(4):490-500. PubMed ID: 34362664
[TBL] [Abstract][Full Text] [Related]
9. Unenhanced breast MRI (STIR, T2-weighted TSE, DWIBS): An accurate and alternative strategy for detecting and differentiating breast lesions.
Telegrafo M; Rella L; Stabile Ianora AA; Angelelli G; Moschetta M
Magn Reson Imaging; 2015 Oct; 33(8):951-5. PubMed ID: 26117691
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance evaluation of multiple myeloma at 3.0 Tesla: how do bone marrow plasma cell percentage and selection of protocols affect lesion conspicuity?
Takasu M; Tamura T; Kaichi Y; Tanitame K; Akiyama Y; Date S; Sakai A; Kuroda Y; Awai K
PLoS One; 2014; 9(1):e85931. PubMed ID: 24489680
[TBL] [Abstract][Full Text] [Related]
11. Pre-treatment staging of multiple myeloma patients: comparison of whole-body diffusion weighted imaging with whole-body T1-weighted contrast-enhanced imaging.
Squillaci E; Bolacchi F; Altobelli S; Franceschini L; Bergamini A; Cantonetti M; Simonetti G
Acta Radiol; 2015 Jun; 56(6):733-8. PubMed ID: 24973257
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted MR imaging with background body signal suppression (DWIBS) for the diagnosis of malignant and benign breast lesions.
Stadlbauer A; Bernt R; Gruber S; Bogner W; Pinker K; van der Riet W; Haller J; Salomonowitz E
Eur Radiol; 2009 Oct; 19(10):2349-56. PubMed ID: 19415286
[TBL] [Abstract][Full Text] [Related]
13. MR evaluation of breast lesions obtained by diffusion-weighted imaging with background body signal suppression (DWIBS) and correlations with histological findings.
Moschetta M; Telegrafo M; Rella L; Capolongo A; Stabile Ianora AA; Angelelli G
Magn Reson Imaging; 2014 Jul; 32(6):605-9. PubMed ID: 24721005
[TBL] [Abstract][Full Text] [Related]
14. Improved contrast for myeloma focal lesions with T2-weighted Dixon images compared to T1-weighted images.
Danner A; Brumpt E; Alilet M; Tio G; Omoumi P; Aubry S
Diagn Interv Imaging; 2019 Sep; 100(9):513-519. PubMed ID: 31130374
[TBL] [Abstract][Full Text] [Related]
15. Relevance of diffusion-weighted imaging with background body signal suppression for staging, prognosis, morphology, treatment response, and apparent diffusion coefficient in plasma-cell neoplasms: A single-center, retrospective study.
Yamada A; Araki Y; Tanaka Y; Otsuki S; Yamada A; Moriyama M; Katagiri S; Suguro T; Asano M; Yoshizawa S; Akahane D; Furuya N; Fujimoto H; Okabe S; Gotoh M; Suzuki K; Saito K; Gotoh A
PLoS One; 2021; 16(7):e0253025. PubMed ID: 34242226
[TBL] [Abstract][Full Text] [Related]
16. Effect of gadolinium injection on diffusion-weighted imaging with background body signal suppression (DWIBS) imaging of breast lesions.
Moschetta M; Telegrafo M; Rella L; Stabile Ianora AA; Angelelli G
Magn Reson Imaging; 2014 Dec; 32(10):1242-6. PubMed ID: 25127984
[TBL] [Abstract][Full Text] [Related]
17. Assessing the relation between bone marrow signal intensity and apparent diffusion coefficient in diffusion-weighted MRI.
Padhani AR; van Ree K; Collins DJ; D'Sa S; Makris A
AJR Am J Roentgenol; 2013 Jan; 200(1):163-70. PubMed ID: 23255758
[TBL] [Abstract][Full Text] [Related]
18. Assessment of naive indolent lymphoma using whole-body diffusion-weighted imaging and T2-weighted MRI: results of a prospective study in 30 patients.
Hong GS; Chae EJ; Ryu JS; Chae SY; Lee HS; Yoon DH; Suh C
Cancer Imaging; 2021 Jan; 21(1):5. PubMed ID: 33413685
[TBL] [Abstract][Full Text] [Related]
19. Deep Learning for Automatic Bone Marrow Apparent Diffusion Coefficient Measurements From Whole-Body Magnetic Resonance Imaging in Patients With Multiple Myeloma: A Retrospective Multicenter Study.
Wennmann M; Neher P; Stanczyk N; Kahl KC; Kächele J; Weru V; Hielscher T; Grözinger M; Chmelik J; Zhang KS; Bauer F; Nonnenmacher T; Debic M; Sauer S; Rotkopf LT; Jauch A; Schlamp K; Mai EK; Weinhold N; Afat S; Horger M; Goldschmidt H; Schlemmer HP; Weber TF; Delorme S; Kurz FT; Maier-Hein K
Invest Radiol; 2023 Apr; 58(4):273-282. PubMed ID: 36256790
[TBL] [Abstract][Full Text] [Related]
20. Bone metastases from prostate, breast and multiple myeloma: differences in lesion conspicuity at short-tau inversion recovery and diffusion-weighted MRI.
Pearce T; Philip S; Brown J; Koh DM; Burn PR
Br J Radiol; 2012 Aug; 85(1016):1102-6. PubMed ID: 22457319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
